TP53 and breast carcinoma: Given that strong p53 immunostaining of tumour tissue was reported to be predictive of TP53 mutations in various human cancers, including breast carcinoma [15] we evaluated whether p53 positive tumour cells were actively proliferating by performing IHC analysis of a proliferative marker Ki67.